Eva Hadadi

Professor Eva Hadadi is an academic researcher at Vrije Universiteit Brussel (VUB) in Brussels, Belgium. She serves as academic staff for two research teams: the Myeloid Cell Immunology Team and the Dendritic Cell Biology & Cancer Immunotherapy Team. Her research focuses on immunology, particularly myeloid cells and their role in cancer and immune responses.

Her research interests include immunology, cancer immunotherapy, myeloid cell biology, dendritic cell biology, circadian rhythm, and tumor microenvironment. She has published extensively on macrophage function in various contexts including cancer, infection, and circadian regulation. Her work often explores how immune cells like macrophages and dendritic cells interact with tumors and how these interactions can be manipulated for therapeutic benefit.

Analysis of her publication history shows a clear progression from fundamental immunology research to more translational cancer immunotherapy approaches. Her recent work (2022-2025) focuses on tumor microenvironment, macrophage heterogeneity, and novel immunotherapeutic strategies including mRNA-based approaches. She has also maintained a parallel interest in circadian biology and its implications for cancer therapy.

Professor Hadadi leads research in two specialized teams at VUB: the Myeloid Cell Immunology Team and the Dendritic Cell Biology & Cancer Immunotherapy Team. These teams appear to focus on understanding how myeloid cells (particularly macrophages and dendritic cells) function in cancer contexts and how this knowledge can be translated into novel immunotherapies. Her research often involves complex in vivo models to study tumor-immune interactions in various anatomical locations including breast tissue and the peritoneal cavity.